Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Garnero

Showing results (71-80 of 119) with videos related to

Pageof 12
Sort By:
The Prostate|December 24, 2005
Prognostic value of PINP, bone alkaline phosphatase, CTX-I, and YKL-40 in patients with metastatic prostate carcinomaKlaus Brasso, Ib Jarle Christensen, Julia S Johansen, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 30, 2008
Effects of PTH and alendronate on type I collagen isomerization in postmenopausal women with osteoporosis: the PaTH studyPatrick Garnero, Doug C Bauer, Emmanuel Mareau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2007
Changes of biochemical markers of bone turnover and YKL-40 following hormonal treatment for metastatic prostate cancer are related to survivalJulia S Johansen, Klaus Brasso, Peter Iversen, et al.
Bone|November 8, 2005
Extracellular post-translational modifications of collagen are major determinants of biomechanical properties of fetal bovine cortical bonePatrick Garnero, Olivier Borel, Evelyne Gineyts, et al.
Cancer|May 7, 2008
Normalization of bone markers is associated with improved survival in patients with bone metastases from solid tumors and elevated bone resorption receiving zoledronic acidAllan Lipton, Richard Cook, Fred Saad, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 21, 2009
Biochemical markers of bone turnover, hip bone loss, and fracture in older men: the MrOS studyDouglas C Bauer, Patrick Garnero, Stephanie L Harrison, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 19, 2006
Pretreatment levels of bone turnover and the antifracture efficacy of alendronate: the fracture intervention trialDouglas C Bauer, Patrick Garnero, Marc C Hochberg, et al.
Seminars in Arthritis and Rheumatism|April 22, 2011
Clinical utility of serum bone turnover markers in postmenopausal osteoporosis therapy monitoring: a systematic reviewThomas Funck-Brentano, Emmanuel Biver, Florence Chopin, et al.
European Journal of Haematology|June 10, 2010
First-line treatment with bortezomib rapidly stimulates both osteoblast activity and bone matrix deposition in patients with multiple myeloma, and stimulates osteoblast proliferation and differentiation in vitroThomas Lund, Kent Søe, Niels Abildgaard, et al.
The Journal of Nutrition|October 2, 2003
The DASH diet and sodium reduction improve markers of bone turnover and calcium metabolism in adultsPao-Hwa Lin, Fiona Ginty, Lawrence J Appel, et al.
Pageof 12

Showing results (71-80 of 119) with videos related to

Sort By:
Pageof 12
The Prostate|December 24, 2005
Prognostic value of PINP, bone alkaline phosphatase, CTX-I, and YKL-40 in patients with metastatic prostate carcinomaKlaus Brasso, Ib Jarle Christensen, Julia S Johansen, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 30, 2008
Effects of PTH and alendronate on type I collagen isomerization in postmenopausal women with osteoporosis: the PaTH studyPatrick Garnero, Doug C Bauer, Emmanuel Mareau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2007
Changes of biochemical markers of bone turnover and YKL-40 following hormonal treatment for metastatic prostate cancer are related to survivalJulia S Johansen, Klaus Brasso, Peter Iversen, et al.
Bone|November 8, 2005
Extracellular post-translational modifications of collagen are major determinants of biomechanical properties of fetal bovine cortical bonePatrick Garnero, Olivier Borel, Evelyne Gineyts, et al.
Cancer|May 7, 2008
Normalization of bone markers is associated with improved survival in patients with bone metastases from solid tumors and elevated bone resorption receiving zoledronic acidAllan Lipton, Richard Cook, Fred Saad, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 21, 2009
Biochemical markers of bone turnover, hip bone loss, and fracture in older men: the MrOS studyDouglas C Bauer, Patrick Garnero, Stephanie L Harrison, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 19, 2006
Pretreatment levels of bone turnover and the antifracture efficacy of alendronate: the fracture intervention trialDouglas C Bauer, Patrick Garnero, Marc C Hochberg, et al.
Seminars in Arthritis and Rheumatism|April 22, 2011
Clinical utility of serum bone turnover markers in postmenopausal osteoporosis therapy monitoring: a systematic reviewThomas Funck-Brentano, Emmanuel Biver, Florence Chopin, et al.
European Journal of Haematology|June 10, 2010
First-line treatment with bortezomib rapidly stimulates both osteoblast activity and bone matrix deposition in patients with multiple myeloma, and stimulates osteoblast proliferation and differentiation in vitroThomas Lund, Kent Søe, Niels Abildgaard, et al.
The Journal of Nutrition|October 2, 2003
The DASH diet and sodium reduction improve markers of bone turnover and calcium metabolism in adultsPao-Hwa Lin, Fiona Ginty, Lawrence J Appel, et al.
Pageof 12